Article ID Journal Published Year Pages File Type
4349654 Neuroscience Letters 2007 6 Pages PDF
Abstract

The transcription factor nuclear factor κB (NF-κB) is widely expressed in the nervous system and increased NF-κB immunoreactivity has been observed in Alzheimer's disease (AD) brains in the nuclei of neurons within the vicinity of diffuse β-amyloid plaques. β-Amyloid (Aβ) peptides are the main constituent of senile plaques and are known to stimulate NF-κB activity. In the present study, we investigated the effect of various NF-κB inhibitors on the production of Aβ1–40, Aβ1–42, secreted APP (sAPPβ and sAPPα) and APP C-terminal fragments (APP-CTF) using CHO cells overexpressing the β-amyloid precursor protein (APP). Our data show that NF-κB inhibitors decrease both Aβ1–40 and Aβ1–42 production. In addition, we show that some NF-κB inhibitors decrease sAPPβ and APP-CTFβ suggesting that they reduce the β-secretase cleavage of APP. Altogether our data suggest that NF-κB inhibitors may be of therapeutic importance for the treatment of AD pathology not only by blocking inflammatory processes but also by directly inhibiting the production of Aβ peptides.

Related Topics
Life Sciences Neuroscience Neuroscience (General)
Authors
, , , , , , ,